Allen Moton

680 total citations
16 papers, 544 citations indexed

About

Allen Moton is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Allen Moton has authored 16 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Allen Moton's work include Antifungal resistance and susceptibility (7 papers), Respiratory and Cough-Related Research (3 papers) and Asthma and respiratory diseases (3 papers). Allen Moton is often cited by papers focused on Antifungal resistance and susceptibility (7 papers), Respiratory and Cough-Related Research (3 papers) and Asthma and respiratory diseases (3 papers). Allen Moton collaborates with scholars based in United States, Switzerland and New Zealand. Allen Moton's co-authors include Gopal Krishna, James F. McLeod, Lei Ma, Matthew M. Medlock, Lei Ma, Monika Martinho, Michael Seiberling, Edward O’Mara, Richard A. Preston and M. Martinho and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmaceutical Sciences and Clinical Pharmacology & Therapeutics.

In The Last Decade

Allen Moton

16 papers receiving 534 citations

Peers

Allen Moton

EPIDE

PHARM

PRM

PPCH

Elizabeth Migoya United States

Rosa María López Spain

S. J. Roffey United Kingdom

Pierre Comby France

R.E. Aarnoutse Netherlands

Monika Martinho United States

Matthew M. Medlock United States

Melissa Engle United States

Philip M. Colangelo United States

Belle L. Lee United States

Elizabeth Migoya United States

Allen Moton

235 ×0.7

161 ×0.6

EPIDE

139 ×1.7

PHARM

76 ×1.1

PRM

63 ×0.9

PPCH

Citations per year, relative to Allen Moton Allen Moton (= 1×) peers Elizabeth Migoya

Countries citing papers authored by Allen Moton

Since Specialization

Citations

This map shows the geographic impact of Allen Moton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allen Moton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allen Moton more than expected).

Fields of papers citing papers by Allen Moton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allen Moton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allen Moton. The network helps show where Allen Moton may publish in the future.

Co-authorship network of co-authors of Allen Moton

This figure shows the co-authorship network connecting the top 25 collaborators of Allen Moton. A scholar is included among the top collaborators of Allen Moton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allen Moton. Allen Moton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Arnold, Lesley M., et al.. (2024). Safety and Tolerability of Esreboxetine in Fibromyalgia: Results from an Open-label, Flexible-dose, Phase 3 Extension Study. Journal of Pain. 25(4). 35–35. 1 indexed citations

Beasley, Richard, James F. Donohue, Rajendra H. Mehta, et al.. (2015). Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial. BMJ Open. 5(2). e006131–e006131. 22 indexed citations

Beasley, Richard, Bob Lanier, István Várkonyi, et al.. (2012). Safety of once-daily QMF149 in patients with persistent asthma. 40. 2093. 2 indexed citations

Beasley, Richard, et al.. (2012). Long-term efficacy of QMF149 in persistent asthma. 40. 1791. 1 indexed citations

Krishna, Gopal, et al.. (2011). Effect of posaconazole on the pharmacokinetics of simvastatin and midazolam in healthy volunteers. Expert Opinion on Drug Metabolism & Toxicology. 8(1). 1–10. 35 indexed citations

Kamal, Mohamed, David E. Smith, Jack Cook, et al.. (2010). Pharmacodynamic Differentiation of Lorazepam Sleepiness and Dizziness Using an Ordered Categorical Measure. Journal of Pharmaceutical Sciences. 99(8). 3628–3641. 5 indexed citations

Corrigan, Brian, et al.. (2009). Effect of renal impairment on the pharmacokinetics of PD 0200390, a novel ligand for the voltage‐gated calcium channel alpha‐2‐delta subunit. British Journal of Clinical Pharmacology. 68(2). 174–180. 5 indexed citations

Moton, Allen, et al.. (2009). Tolerability and safety profile of posaconazole: evaluation of 18 controlled studies in healthy volunteers. Journal of Clinical Pharmacy and Therapeutics. 34(3). 301–311. 38 indexed citations

Krishna, Gopal, Allen Moton, Lei Ma, et al.. (2009). Effects of Oral Posaconazole on the Pharmacokinetics of Atazanavir Alone and With Ritonavir or With Efavirenz in Healthy Adult Volunteers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(4). 437–444. 23 indexed citations

10.

Moton, Allen, Lei Ma, Gopal Krishna, et al.. (2009). Effects of oral posaconazole on the pharmacokinetics of sirolimus. Current Medical Research and Opinion. 25(3). 701–707. 44 indexed citations

11.

Krishna, Gopal, Allen Moton, Lei Ma, et al.. (2009). Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: A phase I, randomized, open-label, crossover study in healthy volunteers. Clinical Therapeutics. 31(2). 286–298. 49 indexed citations

12.

Moton, Allen, Gopal Krishna, Lei Ma, et al.. (2009). Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment. Current Medical Research and Opinion. 26(1). 1–7. 33 indexed citations

13.

Krishna, Gopal, Allen Moton, Lei Ma, Matthew M. Medlock, & James F. McLeod. (2008). Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 53(3). 958–966. 283 indexed citations

14.

Moton, Allen, et al.. (2005). Feasibility of assessing differential pharmacodynamic (PD)/adverse events (AE) profiles on CNS agents. Clinical Pharmacology & Therapeutics. 77(2). P27–P27. 1 indexed citations

15.

Kamal, Mohamed, et al.. (2005). Comparison of continuous and ordered categorical psychometric scales in measuring the time course of lorazepam induced somnolence. Clinical Pharmacology & Therapeutics. 77(2). P66–P66. 1 indexed citations

16.

Pierce, Mark, Allen Moton, & Alan R. Kugler. (2001). Proof of principle trials: exploratory open studies. Epilepsy Research. 45(1-3). 19–21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact